Sphera Funds Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
Sphera Funds Management's CTMX Position: Q3 2026 in Review
Sphera Funds Management reduced its CytomX Therapeutics (CTMX) stake by 86% in Q3 2026, selling an estimated $2.51M and leaving 125,395 shares worth $341K. The position accounts for 0.05% of the portfolio, ranked #107.
Sphera Funds Management first reported a position in CTMX in Q1 2017 and has held it in 12 quarters since. The position peaked at $5.12M in Q1 2018. 194 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- Sphera Funds Management held 125,395 shares of CytomX Therapeutics worth $341K as of Q3 2026.
- Sphera Funds Management sold 753,605 CytomX Therapeutics shares in Q3 2026, an estimated $2.51M.
- CytomX Therapeutics made up 0.05% of Sphera Funds Management's portfolio in Q3 2026, its #107 holding.
- Sphera Funds Management first reported a position in CytomX Therapeutics in Q1 2017 and has held it in 12 quarters since.
- Sphera Funds Management's CytomX Therapeutics position peaked at $5.12M in Q1 2018.
- 194 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on Sphera Funds Management's 13F filing for Q3 2026, filed 16 Nov 2026.